Grünenthal, a global pharmaceutical company based in Aachen, Germany, announced today that it has reached an agreement with Eli Lilly and Company to acquire the commercial rights to Cialis® (tadalafil) in Mexico, Brazil, and Colombia. This acquisition further strengthens Grünenthal’s presence in the Latin American market. As part of the deal, Grünenthal will also take over the manufacturing of…
